Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN64,3764,4-0,17
Msft-0,45
Nokia3,3553,45251,23
IBM0,62
Mercedes-Benz Group AG63,4463,45-0,11
PFE1,59
19.06.2024 1:38:48
Indexy online
AD Index online
select
AD Index online
 

  • 18.06.2024
PetMed Express Rg (PETS.O, NASDAQ Cons)
Závěr k 18.6.2024 Změna (%) Změna (USD) Objem obchodů (ks)
4,32 0,47 0,02 319 576
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 19.06.2024
Popis společnosti
Obecné informace
Název společnostiPetmed Express Inc
TickerPETS
Kmenové akcie:Ordinary Shares
RICPETS.O
ISIN-
Prioritní akciePreference Shares
Poslední známé roční výsledky31.03.2024
Poslední známé čtvrtletní výsledky31.03.2024
Počet zaměstnanců k 23.05.2023 302
Akcie v oběhu k 15.04.2024 21 148 692
MěnaUSD
Kontaktní informace
Ulice420 South Congress Avenue
MěstoDELRAY BEACH
PSČ33445
ZeměUnited States
Kontatní osobaBrian Prenoveau
Funkce kontaktní osobyInvestor Relations
Telefon15 614 264 444
Fax18006008285
Kontatní telefon15 614 895 315

Business Summary: PetMed Express, Inc., doing business as PetMeds, is a direct-to-consumer pet pharmacy. The Company is an online provider of prescription and non-prescription medications, food, supplements, supplies and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile applications. Its product line contains approximately 15,000 SKUs of pet medications, health products, and supplies. The Company offers various pet supplies, including food, beds, crates, stairs and other pet supplies. PetMeds products include Non-Prescription Medications (OTC) and supplies, and Prescription Medications (Rx). OTC and supplies include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. Rx includes heartworm and flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications.
Financial Summary: BRIEF: For the fiscal year ended 31 March 2024, Petmed Express Inc revenues increased 10% to $281.1M. Net loss totaled $7.5M vs. income of $5.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net loss reflects General and Administrative increase of 32% to $55.2M (expense), Advertising increase of 26% to $24.5M (expense). Dividend per share decreased from $1.20 to $0.60.
Odvětvová klasifikace
TRBC2009Retail - Drugs
TRBC2012Retail - Drugs without Grocery
RBSS2004Retail - Drugs
MGINDUSTRYRetail (Drugs)
MGSECTORServices
NAICSPharmacies and Drug Retailers
NAICSPet and Pet Supplies Retailers
NAICSAll Other Miscellaneous Retailers
NAICS2007Pharmacies and Drug Stores
NAICS2007Pet and Pet Supplies Stores
NAICS2007Electronic Shopping
NAICS1997Pharmacies and Drug Stores
NAICS1997Pet and Pet Supplies Stores
NAICS1997Electronic Shopping and Mail-Order Houses
SICDrug Stores/proprietary Stores
SICDrug Stores/proprietary Stores
SICMisc Retail Stores, Nec



  • Poslední aktualizace: 19.06.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the BoardLeslie Campbell6405.01.202405.01.2024
Chief Financial Officer, Treasurer, Company SecretaryChristine Chambers4617.05.202303.08.2022
Chief Operating OfficerCaroline Conegliano-03.06.202403.06.2024
Chief Digital and Technology OfficerUmesh Sripad-03.06.202403.06.2024
Chief Marketing OfficerCarla Dodds-28.05.202428.05.2024